Related Experiment Videos
Noonan's syndrome. IQ and specific disabilities
American Journal of Diseases of Children (1960)
|August 1, 1979
Summary
Intellectual functioning in Noonan syndrome (NS) varies widely. Specific verbal or praxic disabilities can be masked by overall IQ scores, necessitating further evaluation for appropriate academic placement.
Area of Science:
- Neurodevelopmental Disorders
- Genetics
- Pediatric Neurology
Background:
- Noonan syndrome (NS) is a genetic disorder with variable clinical manifestations.
- Cognitive abilities in NS patients often range from normal to intellectual disability.
- Previous studies highlight cognitive variability, but specific patterns of disability require further investigation.
Purpose of the Study:
- To assess the spectrum of intellectual functioning in male patients with Noonan syndrome.
- To identify the presence and nature of specific cognitive deficits, particularly verbal and praxic (visual-constructional) abilities.
- To emphasize the importance of detailed cognitive assessment for academic placement in NS.
Main Methods:
- Evaluated eight male patients diagnosed with Noonan syndrome, aged 13–26 years.
- Administered IQ tests to determine overall intellectual functioning.
- Analyzed individual performance to identify specific verbal and praxic (visual-constructional) disabilities, considering visual acuity.
Main Results:
- IQ scores ranged from 64 to 127, with a median of 102, indicating wide variability.
- Overall IQ scores masked specific cognitive impairments in several cases.
- Four patients exhibited major praxic disability, and one had substantial verbal disability; three of the praxic deficits were unrelated to visual impairment.
Conclusions:
- Apparent general intellectual disability in Noonan syndrome warrants further investigation for specific cognitive deficits.
- Detailed neuropsychological assessment is crucial for understanding individual cognitive profiles in NS.
- Tailored academic placement based on specific strengths and weaknesses is recommended for individuals with Noonan syndrome.